Pancreatic Cancer Research

ResearcherAmgen (United States)Active in the last 2 years

Jianfeng Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0547-0450; OpenAlex author ID A5101818839. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216607↗
  2. Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers. Last author DOI 10.1002/cpdd.48↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Wei · 1 shared paper, 2024 · strength 0.19
  2. Qi Zhang · 1 shared paper, 2024 · strength 0.19
  3. Jin Li · 1 shared paper, 2024 · strength 0.19
  4. Jian Zhang · 1 shared paper, 2024 · strength 0.19
  5. Tingbo Liang · 1 shared paper, 2024 · strength 0.19
  6. Min Zhu · 1 shared paper, 2013 · strength 0.04
  7. Ian McCaffery · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.